Celltrion Offers 85% Discount For Adalimumab Biosimilar In US
Branded Version Of Celltrion’s Humira Biosimilar Is Available With A 5% Discount
Celltrion joins a number of other adalimumab competitors with dual pricing strategies as Humira biosimilars finally gain some traction in the US market.
